Advertisement

Left Superior Vena Cava in the Fetus: A Rarely Isolated Anomaly

  • Anne-Frédérique Minsart
  • Isabelle BoucoiranEmail author
  • Marie-Ange Delrue
  • François Audibert
  • Sylvia Abadir
  • Chantale Lapierre
  • Emmanuelle Lemyre
  • Marie-Josée Raboisson
Original Article
  • 70 Downloads

Abstract

The frequency of chromosomal anomalies among fetuses with isolated persistent left superior vena cava (PLSVC) is still debated. The objective of the present study was to assess the prevalence of genetic and morphological anomalies identified in fetuses with PLSVC. We conducted a single-center retrospective study including all fetuses diagnosed with a PLSVC between 2010 and 2017. PLSVC was categorized as isolated or associated according to antenatal diagnosis of associated congenital heart defects, hypoplastic aortic isthmus, abnormal venous/arterial connections, and extracardiac anomalies. Among 229 fetuses diagnosed with PLSVC, 39 cases (17%) were strictly isolated and no syndromic/genetic anomaly or aortic coarctation was diagnosed. Seventy-two fetuses had a cardiovascular defect with a rate of genetic anomalies of 22%, 29 had an extracardiac malformation, and 89 had both an extracardiac and a cardiovascular defect. Among fetuses with abnormal development of the arterial/venous system as the only associated anomaly such as aberrant right subclavian artery or absent ductus venosus, 22% had a genetic anomaly. Overall, sixty-five fetuses or infants had a genetic concern, including 23 aneuploidies, 15 pathogenic micro-deletions/duplications, and 5 variants of unknown significance; 12 patients had VACTERL association, and 12 heterotaxy syndrome. Seven infants had an aortic coarctation diagnosed at birth.

In conclusion, a thorough prenatal ultrasound examination is paramount, and the identification of variants of the venous/arterial system in addition to PLSVC should raise suspicion for genetic or morphologic abnormalities. Invasive prenatal diagnosis with array-CGH should be offered when PLSVC is non-isolated, after a detailed ultrasound evaluation in a tertiary center.

Keywords

Aortic coarctation (MeSH) Echocardiography (MeSH) Genetic diseases Persistent left superior vena cava Prenatal diagnosis (MeSH) Ultrasonography Prenatal (MeSH) 

Notes

Acknowledgements

The authors wish to thank Annie Berger, Sophie Brisebois, and Heidi Shapiro for their help in data collection and corrections.

Author Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Anne-Frederique Minsart and Marie-Josee Raboisson. The first draft of the manuscript was written by Anne-Frederique Minsart and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Funding

IB is a recipient of a salary award (chercheur-boursier) from FRQ-S (Quebec’s Health research fund) and is supported by a team grant of the Canadian Institutes for Health Research. These funding bodies have no role in the design, analysis, and interpretation of data. This research was presented orally at the 53rd Annual meeting of the Association for European Paediatric and Congenital Cardiology, 15–18 May 2019, Seville, Spain.

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (CHU Sainte-Justine Ethics and Research Committee, Project 2019–2041) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

References

  1. 1.
    Cherian SB, Ramesh BR, Madhyastha S (2006) Persistent left superior vena cava. Clin Anat 19:561–565CrossRefGoogle Scholar
  2. 2.
    Sheikh AS, Mazhar S (2014) Persistent left superior vena cava with absent right superior vena cava: review of the literature and clinical implications. Echocardiography 31:674–679CrossRefGoogle Scholar
  3. 3.
    Postema PG, Rammeloo LA, van Litsenburg R, Rothuis EG, Hruda J (2008) Left superior vena cava in pediatric cardiology associated with extra-cardiac anomalies. Int J Cardiol 123:302–306CrossRefGoogle Scholar
  4. 4.
    Perles Z, Nir A, Gavri S, Golender J, Tashma A, Ergaz Z, Rein AJ (2013) Prevalence of persistent superior vena cava and association with congenital heart anomalies. Am J Cardiol 112:1214–1218CrossRefGoogle Scholar
  5. 5.
    Du L, Xie HN, Zhu YX, Li LJ, Peng R, Zheng J (2014) Fetal persistent left superior vena cava in cases with and without chromosomal anomalies. Prenat Diagn 34:797–802CrossRefGoogle Scholar
  6. 6.
    Choi EY, Hong SK, Jeong NY (2016) Clinical characteristics of prenatally diagnosed persistent left superior vena cava in low-risk pregnancies. Prenat Diagn 36:444–448CrossRefGoogle Scholar
  7. 7.
    Esmer AC, Yuksel A, Cali H, Ozsurmeli M, Omeroglu RE, Kalelioglu I, Has R (2014) Prenatal diagnosis of persistent left superior vena cava and its clinical significance. Balkan Med J 31:50–54PubMedPubMedCentralGoogle Scholar
  8. 8.
    Barrea C, Ovaert C, Moniotte S, Biard JM, Steenhaut P, Bernard P (2011) Prenatal diagnosis of abnormal cardinal systemic venous return without other heart defects: a case series. Prenat Diagn 31:380–388CrossRefGoogle Scholar
  9. 9.
    Rizzo G, Arduini D, Capponi A (2008) Use of the multiplanar display in evaluation of a persistent left superior vena cava in the fetal heart using 4-dimensional ultrasonography: advantage of adding the spin technique. J Ultrasound Med 27:497–498PubMedGoogle Scholar
  10. 10.
    Galindo A, Gutierrez-Larraya F, Escribano D, Arbues J, Velasco JM (2007) Clinical significance of persistent left superior vena cava diagnosed in fetal life. Ultrasound Obstet Gynecol 30:152–161CrossRefGoogle Scholar
  11. 11.
    Berg C, Knuppel M, Geipel A, Kohl T, Krapp M, Knopfle G, Germer U, Hansmann M, Gembruch U (2006) Prenatal diagnosis of persistent left superior vena cava and its associated congenital anomalies. Ultrasound Obstet Gynecol 27:274–280CrossRefGoogle Scholar
  12. 12.
    Pasquini L, Fichera A, Tan T, Ho SY, Gardiner H (2005) Left superior caval vein: a powerful indicator of fetal coarctation. Heart 91:539–540CrossRefGoogle Scholar
  13. 13.
    Machevin-Surugue E, David N, Verspyck E, Labadie G, Blaysat G, Durand I, Ickowicz V, Marpeau L (2002) Dilated coronary sinus in prenatal echocardiography; identification, associations and outcome. Prenat Diagn 22:898–902CrossRefGoogle Scholar
  14. 14.
    Gustapane S, Leombroni M, Khalil A, Giacci F, Marrone L, Bascietto F, Rizzo G, Acharya G, Liberati M, D'Antonio F (2016) Systematic review and meta-analysis of persistent left superior vena cava on prenatal ultrasound: associated anomalies, diagnostic accuracy and postnatal outcome. Ultrasound Obstet Gynecol 48:701–708CrossRefGoogle Scholar
  15. 15.
    Ozsurmeli M, Buyukkurt S, Sucu M, Arslan E, Akcabay C, Misirlioglu S, Kayapinar M, Ozbarlas N, Demir SC, Evruke C (2019) Prenatal diagnosis of persistent left superior vena cava: a retrospective study of associated congenital anomalies. Turk J Obstet Gynecol 16:23–28CrossRefGoogle Scholar
  16. 16.
    Committee on Genetics, the Society for Maternal-Fetal Medicine (2016) Committee opinion no. 682: microarrays and next-generation sequencing technology: the use of advanced genetic diagnostic tools in obstetrics and gynecology. Obstet Gynecol 128:e262–e268CrossRefGoogle Scholar
  17. 17.
    Lee W, Allan L, Carvalho JS, Chaoui R, Copel J, Devore G, Hecher K, Munoz H, Nelson T, Paladini D, Yagel S, Force IFET (2008) ISUOG consensus statement: what constitutes a fetal echocardiogram? Ultrasound Obstet Gynecol 32:239–242CrossRefGoogle Scholar
  18. 18.
    Cargill Y, Morin L, Diagnostic Imaging C (2009) Content of a complete routine second trimester obstetrical ultrasound examination and report. J Obstet Gynaecol Can 31:272–275CrossRefGoogle Scholar
  19. 19.
    Audibert F, De Bie I, Johnson JA, Okun N, Wilson RD, Armour C, Chitayat D, Kim R (2017) No. 348-Joint SOGC-CCMG guideline: update on prenatal screening for fetal aneuploidy, fetal anomalies, and adverse pregnancy outcomes. J Obstet Gynaecol Can 39:805–817CrossRefGoogle Scholar
  20. 20.
    Summers AM, Langlois S, Wyatt P, Douglas Wilson R (2007) Prenatal screening for fetal aneuploidy. J Obstet Gynaecol Can 29:146–161CrossRefGoogle Scholar
  21. 21.
    International Society of Ultrasound in O, Gynecology, Carvalho JS, Allan LD, Chaoui R, Copel JA, DeVore GR, Hecher K, Lee W, Munoz H, Paladini D, Tutschek B, Yagel S (2013) ISUOG practice guidelines (updated): sonographic screening examination of the fetal heart. Ultrasound Obstet Gynecol 41:348–359CrossRefGoogle Scholar
  22. 22.
    Familiari A, Morlando M, Khalil A, Sonesson SE, Scala C, Rizzo G, Del Sordo G, Vassallo C, Elena Flacco M, Manzoli L, Lanzone A, Scambia G, Acharya G, D’Antonio F (2017) Risk factors for coarctation of the aorta on prenatal ultrasound: a systematic review and meta-analysis. Circulation 135:772–785CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of Maternal-Fetal Medicine, Department of Obstetrics and GynecologyCHU Sainte-JustineMontrealCanada
  2. 2.Department of GeneticsUniversité de Montréal - Sainte-Justine University HospitalMontrealCanada
  3. 3.Department of Fetal and Pediatric CardiologyUniversité de Montréal - Sainte-Justine University HospitalMontrealCanada
  4. 4.Department of RadiologyUniversité de Montréal - Sainte-Justine University HospitalMontrealCanada

Personalised recommendations